The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment

por Uche, Ifeanyi Kingsley, Kousoulas, Konstantin G., Rider, Paul J. F.
Publicado 2021

Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines

por Uche, Ifeanyi Kingsley, Stanfield, Brent A., Rudd, Jared S., Kousoulas, Konstantin G., Rider, Paul J. F.
Publicado 2022

Identification and Visualization of Functionally Important Domains and Residues in Herpes Simplex Virus Glycoprotein K(gK) Using a Combination of Phylogenetics and Protein Modeling

por Rider, Paul J. F., Coghill, Lyndon M., Naderi, Misagh, Brown, Jeremy M., Brylinski, Michal, Kousoulas, Konstantin G.
Publicado 2019

Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors

por Singha, Manali, Pu, Limeng, Stanfield, Brent A., Uche, Ifeanyi K., Rider, Paul J. F., Kousoulas, Konstantin G., Ramanujam, J., Brylinski, Michal
Publicado 2022

An Attenuated HSV-1-Derived Malaria Vaccine Expressing Liver-Stage Exported Proteins Induces Sterilizing Protection against Infectious Sporozoite Challenge

por Rider, Paul J. F., Kamil, Mohd, Yilmaz, Ilknur, Atmaca, Habibe N., Kalkan-Yazici, Merve, Ziya Doymaz, Mehmet, Kousoulas, Konstantin G., Aly, Ahmed S. I.
Publicado 2022

Unlocking the Potential of Kinase Targets in Cancer: Insights from CancerOmicsNet, an AI-Driven Approach to Drug Response Prediction in Cancer

por Singha, Manali, Pu, Limeng, Srivastava, Gopal, Ni, Xialong, Stanfield, Brent A., Uche, Ifeanyi K., Rider, Paul J. F., Kousoulas, Konstantin G., Ramanujam, J., Brylinski, Michal
Publicado 2023

Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Me...

por Uche, Ifeanyi Kingsley, Fowlkes, Natalie, Vu, Luan, Watanabe, Tatiane, Carossino, Mariano, Nabi, Rafiq, del Piero, Fabio, Rudd, Jared S., Kousoulas, Konstantin G., Rider, Paul J. F.
Publicado 2021

45724 VC2 Oncolytic Virotherapy Induces Robust Systemic Anti-Tumor Immunity and Increases Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model

por Uche, Ifeanyi Kingsley, Fowlkes, Natalie, Vu, Luan, Watanabe, Tatiane, Carossino, Mariano, Nabi, Rafiq, Del Piero, Fabio, Rudd, Jared S., Kousoulas, Konstantin G., Rider, Paul J.F.
Publicado 2021